Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Actrapid 100units/ml solution for injection 10ml vials
0601011N0BFAEAL
|
Insulin soluble (Novo-Nordisk) | Soluble insulin (Neutral insulin) | Endocrine System | 1,453 |
|
Actrapid NovoLet 100units/ml solution for injection
0601011N0BFAPAM
|
Insulin soluble (Novo-Nordisk) | Soluble insulin (Neutral insulin) | Endocrine System | No data available |
|
Actrapid Penfill 100units/ml inj 3ml cartridges
0601011N0BFAQAP
|
Insulin soluble (Novo-Nordisk) | Soluble insulin (Neutral insulin) | Endocrine System | No data available |
|
Human Actrapid Penfill 100units/ml inj 1.5ml cartridges
0601011N0BFAJAD
|
Insulin soluble (Novo-Nordisk) | Soluble insulin (Neutral insulin) | Endocrine System | No data available |
|
Pork Actrapid 100units/ml solution for injection 10ml vials
0601011N0BFASAC
|
Insulin soluble (Novo-Nordisk) | Soluble insulin (Neutral insulin) | Endocrine System | No data available |
|
Velosulin 100units/ml solution for injection 10ml vials
0601011N0BFACAL
|
Insulin soluble (Novo-Nordisk) | Soluble insulin (Neutral insulin) | Endocrine System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.